Association between transforming growth factor-β1 gene C-509T and T869C polymorphisms and rheumatic heart disease

American Heart Journal

Volumn 148, Issue 1, 2004, Pages 181-186

  Chou, Hsiang Tai ^a   Chen, Chien Hsiun ^c   Tsai, Chang Hai ^b   Tsai, Fuu Jen ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; STATISTICAL SIGNIFICANCE; TAIWAN;

ADULT; AGED; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETICS, POPULATION; GENOTYPE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; POLYMORPHISM, GENETIC; RHEUMATIC HEART DISEASE; SEVERITY OF ILLNESS INDEX; TAIWAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 3142653062     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.03.032     Document Type: Article

References (37)

1. Stollermann G.H. Rheumatic fever. Lancet. 349:1997;935-942
2. Zabriskie J.B. Rheumatic fever a model for the pathological consequences of microbial-host mimicry. Clin Exp Rheumatol. 4:1986;65-73
3. Cunningham M. Molecular mimicry between group A streptococci and myosin in the pathogenesis of acute rheumatic fever. Narula J., Virmani R., Reddy K.S.,, et al. Rheumatic fever. 1999;135-165 Armed Forces Institute of Pathology, Washington, DC
4. DiSciascio G., Taranta A. Rheumatic fever in children. Am Heart J. 99:1980;635-658
5. Pickles W.N. Rheumatic family. Lancet. 2:1943;241
6. Jian B., Narula N., Li Q.Y., et al. Progression of aortic valve stenosis TGF-β1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg. 75:2003;457-465
7. Fielitz J., Hein S., Mitrovic V., et al. Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol. 37:2001;1443-1449
8. Border W.A., Noble N.A. Transforming growth factor β in tissue fibrosis. N Engl J Med. 331:1994;1286-1292
9. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet. 29:2001;117-129
10. Teicher B.A. Malignant cells, directors of the malignant process role of transforming growth factor-beta. Cancer Metastasis Rev. 20:2001;133-143
11. Kinoshita A., Saito T., Tomita H., et al. Domain-specific mutations in TGF-β1 result in Camurati-Engelmann disease. Nat Genet. 26:2000;19-20
12. Campos-Xavier B., Saraiva J.M., Savarirayan R., et al. Phenotypic variability at the TGF-beta1 locus in Camurati-Engelmann disease. Hum Genet. 109:2001;653-658
13. Azuma H. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest. 47:2000;81-90
14. Cheifetz S., Bellon T., Cales C., et al. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem. 267:1992;19027-19030
15. Berg J.N., Gallione C.J., Stenzel T.T., et al. The activin receptor-like kinase 1 gene genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2. Am J Hum Genet. 61:1997;60-67
16. Fujii D., Brissenden J., Derynck R., et al. Transforming growth factor-β gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet. 12:1986;281-288
17. Kim S., Glick A., Sporn M., et al. Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem. 264:1989;402-408
18. Grainger D.J., Heathcote K., Chiano M., et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet. 8:1999;93-97
19. Holweg C.T., Baan C.C., Balk A.H., et al. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation. 71:2001;1463-1467
20. Chou H.T., Shi Y.R., Hsu Y., et al. Lack of association between transforming growth factor-β1 gene polymorphism and mitral valve prolapse in Taiwan Chinese. J Heart Valve Dis. 11:2002;478-484
21. Xie X., Ott J. Testing linkage disequilibrium between a disease gene and marker loci (abstract). Am J Hum Genet. 53:1993;1107
22. Terwilliger J., Ott J. Handbook of Human Geneitc tinkage. 1994;Johns Hopkins University Press, Baltimore
23. Carlquist J.F., Ward R.H., Meyer K.J., et al. Immune response factors in rheumatic heart disease meta-analysis of HLA-DR associations and evaluation of additional class II alleles. J Am Coll Cardiol. 26:1995;452-457
24. Gu J., Yu B., Zhou J. HLA-DQA1 genes involved in genetic susceptibility to rheumatic fever and rheumatic heart disease in southern Hans. Zhonghua Nei Ke Za Zhi. 36:1997;308-311
25. Guilherme L., Weidebach W., Kiss M.H., et al. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation. 83:1991;1995-1998
26. Olson L.J., Subramanian R., Ackerman D.M., et al. Surgical pathology of the mitral valve a study of 712 cases spanning 21 years. Mayo Clin Proc. 62:1987;22-34
27. Guédez Y., Kotby A., El-Demellawy M., et al. HLA class II association with rheumatic heart disease are more evident and consistent among clinically homogeneous patients. Circulation. 99:1999;2784-2790
28. Schoen F.J., St John Sutton M. Contemporary pathologic considerations in valvular disease. Virmani B., Atkinson J.B., Feuoglio J.J. Cardiovascular pathology. 1991;334-353 Saunders, Philadelphia
29. Kawanishi D.T., Rahimtoola S.H. Mitral stenosis. Rahimtoola S.H. Valvular heart disease. II:1996;8.1-8.24 Mosby, St. Louis
30. Atalar E., Tokgözoglu S.L., Alikasifoglu M., et al. Angiotensin-converting enzyme genotype predicts valve damage in acute rheumatic fever. J Heart Valve Dis. 12:2003;7-10
31. Derynck R., Rhee L., Chen E.Y., et al. Intron-exon structure of the human transforming growth factor-β precursor gene. Nucleic Acids Res. 15:1987;3187-3189
32. Assoian R., Komoriya A., Meyers C., et al. Transforming growth factor-β in human platelets. J Biol Chem. 258:1983;7155-7160
33. Sporn M., Roberts A., Wakefield M., et al. Transforming growth factor-β biological function and chemical structure. Science. 233:1986;532-534
34. Ignotz R., Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 261:1986;4337-4345
35. Laiho M., Saksela O., Keski-Oja J., et al. Transforming growth factor-β induction of type-1 plasminogen activator inhibitor. J Biol Chem. 262:1987;17467-17474
36. Xaubet A., Marin-Arguedas A., Lario S., et al. Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 168:2003;431-435
37. Awad M.R., El-Gamel A., Hasleton P., et al. Genotypic variation in the transforming growth factor-β1 gene. Transplantation. 66:1998;1014-1020